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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
03.07.2020 HIV and risk 
of COVID-19 
death: a 
population 
cohort study 
from the 
Western 
Cape 
Province, 
South Africa 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 The effect of HIV co-
infection on C19 in 
SSA is unknown 
 This population cohort 
study found that HIV 
increased risk of C19 
mortality (associated 
with a doubling of C19 
mortality risk), with 
similar risks across 
strata of viral load and 
immunosuppression 
 Current and previous 
TB also increased C19 
mortality risk 
 Authors caution that 
whilst findings may 
over-estimate the HIV-
associated risk C19 
death due to residual 
confounding, it 
remains that those with 
HIV should be 
considered a high-risk 
group for C19 
management 
HIV, TB, 
mortality 
2 
03.07.2020 Prevalence 
and 
experience of 
fatigue in 
survivors of 
critical 
illness: A 
mixed-
methods 
systematic 
review 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 This mixed methods 
review shows that 
fatigue is highly 
prevalent in ICU 
survivors impacting on 
recovery 
 There is currently no 
ICU specific fatigue 
assessment tool or 
targeted intervention to 
manage this symptom 
 This review has 
identified factors which 
may increase or 
mitigate against 
fatigue, along with 
potential management 
strategies for 
consideration in future 
research and practice 
fatigue 
02.07.2020 Neurological 
associations 
of COVID-19 
The Lancet 
Neurology | 
Rapid Review 
 Careful clinical, 
diagnostic, and 
epidemiological 
studies are needed to 
help define the 
manifestations and 
burden of neurological 
disease caused by 
SARS-coV-2 
 The proportion of 
infections leading to 
neurological disease 
will probably remain 
small, however, with 
so many people 
infected the overall 
number of neurological 
patients, and their 
associated health 
burden and social and 
economic costs might 
be large 
 These patients might 
be left with severe 
neurological sequelae 
 Healthcare planners 
and policy makers 
must prepare for this 
neurology 
02.07.2020 Ethnic and 
regional 
variations in 
hospital 
mortality 
The Lancet 
Global Health 
| Article 
 This cross-sectional 
observational study 
aimed to characterise 
the C19 pandemic in 
Brazil and assess 
variations in mortality 
Regional, 
ethnicity, 
socioeconomic 
3 
from COVID-
19 in Brazil: 
a cross-
sectional 
observational 
study 
according to region, 
ethnicity, comorbidities 
and symptoms 
 Finding: increased 
mortality in the north 
region (regional effect) 
– may be driven by 
increasing comorbidity 
burden in regions with 
lower levels of 
socioeconomic 
development 
 Finding: increased 
mortality in the Pardo 
and Black populations 
(ethnicity effect) – may 
be related to 
differences in 
susceptibility to 
COVID-19 and access 
to health care 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
02.07.2020 Community 
vulnerability 
to 
epidemics 
in Nepal: A 
high-
resolution 
spatial 
assessment 
amidst 
COVID-19 
pandemic 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Knowledge of 
community 
vulnerability to C19 
could assist efficient 
deployment of 
available limited 
resources 
 This study assembled 
geospatial indicators to 
create 3 vulnerability 
indices to aid different 
tiers of the existing 
government in federal 
system of Nepal to 
prioritise and improve 
planning for disease 
intervention and 
especially so where 
C19 transmission 
could have high 
severity 
Community 
vulnerability, 
resources 
  
4 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
03.07.2020 Convalescent 
plasma for 
COVID-19. A 
randomized 
clinical trial 
medRxiv (not 
peer-
reviewed) | 
pre-print 
 Convalescent plasma 
could be an inexpensive 
and widely available 
treatment for COVID-
19  
 This randomised trial 
aimed to compare 
convalescent plasma 
with standard of care 
therapy in patients 
hospitalised with C19 in 
the Netherlands 
 The trial was halted 
prematurely though 
after enrolment of 86 
patients. No difference 
in mortality (p=0.95), 
hospital stay (p=0.68) or 
day-15 disease severity 
(p=0.58) was observed 
between plasma treated 
patients and patients on 
standard of care 
 Most C19 patients have 
high neutralising 
antibody titres when 
admitted to hospital. 
Screening for 
antibodies may help 
identify those that may 
benefit most from 
convalescent plasma 
 Convalescent 
plasma 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
01.07.2020 Beyond 
COVID-19: 
A whole of 
health look 
at impacts 
during the 
CGD | Policy 
Paper 
 Substantial evidence has 
emerged relating to the 
potential magnitude of the 
indirect health effects of the 
C19 pandemic 
 This paper provides an 
overview of the lessons 
learned from previous 
Holistic 
approach, 
previous 
lessons 
5 
pandemic 
response 
outbreaks and economic 
crises in relation to indirect 
health effects 
 Also proposes a framework 
for adopting a whole of 
health approach to the C19 
response around 4 distinct by 
interrelated sets of impacts: 
economic, environmental, 
health systems, and 
social/behavioural 
 Authors apply this framework 
to discuss what is already 
known on the indirect health 
impacts of C19 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
04.07.2020 Offline” It’s time to convene nations to 
end this pandemic 
The Lancet | 
Comment 
Richard Horton 
03.07.2020 ‘I’m cautiously optimistic’: Imperial’s 
Robin Shattock on his coronavirus 
vaccine 
The Guardian | 
News 
Sarah Boseley 
02.07.2020 Will covid-19 be the catalyst for a “new 
deal” for the health and wellbeing of 
women, children and adolescents? 
BMJ | Blog Helen Clark 
02.07.2020 After COVID-19, a future for the 
world’s children? 
The Lancet | 
Comment 
The WHO-
UNICEF-Lancet 
Commissioners 
02.07.2020 EU guidance impedes humanitarian 
action to prevent COVID-19 in Syria 
The Lancet Global 
Health | Comment 
Hamid Yahiya 
Hussain 
Kasturi Sen 
02.07.2020 COVID-19 in the Caribbean small 
island developing states: lessons 
learnt from extreme weather events  
The Lancet Global 
Health | Comment 
Ian R Hambleton 
Selvi M 
Jeyaseelan 
6 
Madhuvanti M 
Murphy 
02.07.2020 Beyond lockdown – sustainable 
COVID control for low-income 
countries 
CGD | Blog Peter Baker 
Jeremy 
Konyndyk 
Patrick Saez 
Kalipso 
Chalkidou 
02.07.2020 Out of tragedy comes opportunity: how 
can global health multilateralism seize 
the moment? 
CGD | Blog Julia Kaufmann 
Alexander Winch  
Shu-Shu Tekle-
Haimanot 
Kalipso 
Chalkidou 
01.07.2020 The need for COVID-19 research in 
low- and middle-income countries 
Global Health 
Research and 
Policy | 
Commentary 
Madhu Gupta et 
al.  
01.07.2020 A framework for identifying the sources 
of indirect health effects of COVID-19 
CGD | Blog Y-Ling Chi 
Lydia Regan 
Cassandra 
Nemzoff 
Carleigh Krubiner 
Yasmine Anwar 
Damian Walker 
30.06.2020 WHO & Partners enhance support to 
COVID-19 response in Rohingya 
camps in Cox’s Bazar 
WHO | News   
30.06.2020 Emerging COVID-19 success story: 
Vietnam’s commitment to containment 
Our World In Data | 
Guest post 
Todd Pollack et 
al. 
7 
29.06.2020 Healthcare technologies and COVID-
19: speed is not always a good thing 
CGD | Blog Kalipso 
Chalkidou et al.  
29.06.2020 “As One World we will be stronger” – 
We need words of hope, not war 
language 
ARISE | Blog Alfred Itunga 
Beate Ringwald 
26.06.2020 WHO, partners unveil ambitious plan 
to deliver 2 billion doses of Covid-19 
vaccine to high-risk populations 
STAT |News Helen Branswell 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
2020 Social Science 
Research for 
Vaccine Deployment 
in Epidemic 
Outbreaks 
SSHAP | 
Tool 
 There is a need to understand 
different perspectives on vaccines 
and outbreaks to identify community 
perceptions surrounding vaccine 
use 
 This SSHAP Practical Approaches 
brief can be used by healthcare 
providers/NGOs, national and 
global-level policymakers, and 
industry actors to gain social 
science inputs in vaccine 
deployment efforts to provide 
practical solutions to re-occurring 
challenges, including vaccine 
refusal 
  
8 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
9 
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
10 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
11 
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
  
12 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
07.07.2020 
1300-1430 
BST 
Fifth Annual Health 
Financing Forum 
(AHFF): Health 
Financing Resilience 
and Sustainability 
Online event 1h 30 JLN, WB, USAID, 
GFF, GFF, CGD 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
6:00 PM 
BST 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
Online 
Lecture  
2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
13 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
14 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
